image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - COST OF REVENUE

Cost of Revenue ESPR - Esperion Therapeutics, Inc.

image
43.3 M
LAST VALUE
74.45%
2 YEAR CAGR
177.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR